1985
DOI: 10.1172/jci111773
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in collagen genes. Consequences for rare and common diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0
1

Year Published

1987
1987
2014
2014

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(10 citation statements)
references
References 26 publications
0
9
0
1
Order By: Relevance
“…At the cellular level, the best characterized defect in VLK null animals is in the differentiation of chondrocytes in long bones (Imuta et al, 2009; Kinoshita et al, 2009; Probst et al, 2013). Our studies identify a variety of VLK substrates with established roles in skeletal development, including Type I collagen (Prockop, 1985), MMP13 (Stickens et al, 2004), MIA3 (an essential collagen chaperone) (Wilson et al, 2011), and MESD (a chaperone for the wnt receptor LRP5/6) (Hsieh et al, 2003; Zhang et al, 2004). At this point, it is not possible to assess whether the VLK null phenotype reflects a major functional alteration in one or two key substrates, or more subtle changes in a broad set of functionally interacting substrates that collectively impact chondrocyte differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…At the cellular level, the best characterized defect in VLK null animals is in the differentiation of chondrocytes in long bones (Imuta et al, 2009; Kinoshita et al, 2009; Probst et al, 2013). Our studies identify a variety of VLK substrates with established roles in skeletal development, including Type I collagen (Prockop, 1985), MMP13 (Stickens et al, 2004), MIA3 (an essential collagen chaperone) (Wilson et al, 2011), and MESD (a chaperone for the wnt receptor LRP5/6) (Hsieh et al, 2003; Zhang et al, 2004). At this point, it is not possible to assess whether the VLK null phenotype reflects a major functional alteration in one or two key substrates, or more subtle changes in a broad set of functionally interacting substrates that collectively impact chondrocyte differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…Primers sequences used to amplify these loci are given in Table 1. As noted, the products of all these genes have been shown to regulate either the cell cycle or ECM (Prockop 1985;Chen et al 1989;Tonini et al 1991;Apte et al 1994;Lee et al 1995;Matsuoka et al 1995). We assessed expression levels of these genes at three different time points, namely E10.5 (early placentation), E13.5 (mid-placentation) and E16 (after placental maturation).…”
Section: Microarray Analysismentioning
confidence: 99%
“…We assessed changes in the expression levels of these genes, including Col1a2, Col3a1, Timp1, Timp2 and Timp3, using real-time quantitative RT-PCR assays and semiquantitative radioactive RT-PCR. The procollagen gene family is involved in numerous aspects of matrix stability and development (Prockop 1985). The specific genes identified in our screen include Col1a2 (type I procollagen) and Col3a1 (type III procollagen).…”
Section: Reduced Expression Of Hybrid Ecm Genesmentioning
confidence: 99%
See 1 more Smart Citation
“…An alternative approach would be to introduce mutations into the collagen molecule that would render it resistant to cleavage by collagenase. Many inherited or spontaneous mutations in humans that lead to alterations in the structure and function of collagen have been described (6)(7)(8)(9)(10)(11), but none has been reported that results in altered susceptibility to collagenase cleavage.…”
mentioning
confidence: 99%